As a first step, western blotting was performed for PDGFRα and PDGFRβ in primary mammary tumors (IGF-IR-dependent) and IGF-IR-dependent recurrent tumors of MTB-IGFIR transgenic mice. This evidence concerns the gene PDGFRB and breast cancer.